Medicine recalls
|
| |
| Canada: Recall: Semaglutide + Pyridoxine: produced with an unauthorized active pharmaceutical ingredient |
| |
Health Canada announces that Create Compounding Pharmacy is recalling Semaglutide 1mg/mL + Pyridoxine 15mg/mL in syringe or vial (lot number: N/A) and Semaglutide 2 mg/mL + Pyridoxine 30 mg/mL in syringe or vial (lot number: N/A) from end users because the products were produced with an unauthorized active pharmaceutical ingredient.
Semaglutide is used in the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise, and may be given as monotherapy or combined with other antidiabetic drugs, including insulin, in patients who do not have adequate glycaemic control with standard therapy. Pyridoxine is used in the treatment and prevention of pyridoxine deficiency states.
Please refer to the following website in Health Canada for details:
http://recalls-rappels.canada.ca/en/alert-recall/semaglutide-pyridoxine-produced-unauthorized-active-pharmaceutical-ingredient
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Wednesday, Jan 22, 2025
Issued at HKT 17:00
|
| |
